Cargando…
Utility of iPSC-Derived Cells for Disease Modeling, Drug Development, and Cell Therapy
The advent of induced pluripotent stem cells (iPSCs) has advanced our understanding of the molecular mechanisms of human disease, drug discovery, and regenerative medicine. As such, the use of iPSCs in drug development and validation has shown a sharp increase in the past 15 years. Furthermore, many...
Autores principales: | Nicholson, Martin W., Ting, Chien-Yu, Chan, Darien Z. H., Cheng, Yu-Che, Lee, Yi-Chan, Hsu, Ching-Chuan, Huang, Ching-Ying, Hsieh, Patrick C. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9180434/ https://www.ncbi.nlm.nih.gov/pubmed/35681550 http://dx.doi.org/10.3390/cells11111853 |
Ejemplares similares
-
Human iPSC banking: barriers and opportunities
por: Huang, Ching-Ying, et al.
Publicado: (2019) -
Cells derived from iPSC can be immunogenic — Yes or No?
por: Cao, Jiani, et al.
Publicado: (2014) -
Liver cell reprogramming: Parallels with iPSC biology
por: Yanger, Kilangsungla, et al.
Publicado: (2014) -
Maturing iPSC-Derived Cardiomyocytes
por: Tang, Bor Luen
Publicado: (2020) -
Induced Pluripotent Stem Cell (iPSC)-Based Neurodegenerative Disease Models for Phenotype Recapitulation and Drug Screening
por: Chang, Chia-Yu, et al.
Publicado: (2020)